Paulukonis S - Search Results

1

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.

Wong TE, Valle J, Paulukonis S. Wong TE, et al. Among authors: paulukonis s. Health Sci Rep. 2021 Jul 14;4(3):e323. doi: 10.1002/hsr2.323. eCollection 2021 Sep. Health Sci Rep. 2021. PMID: 34277954 Free PMC article.

2

Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California.

Valle J, Roberts E, Paulukonis S, Collins N, English P, Kaye W. Valle J, et al. Among authors: paulukonis s. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):209-15. doi: 10.3109/21678421.2015.1019516. Epub 2015 Mar 30. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25822003 Free PMC article.

3

Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Paulukonis ST, Roberts EM, Valle JP, Collins NN, English PB, Kaye WE. Paulukonis ST, et al. PLoS One. 2015 Jul 14;10(7):e0131965. doi: 10.1371/journal.pone.0131965. eCollection 2015. PLoS One. 2015. PMID: 26172548 Free PMC article.

4

Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. Paulukonis ST, et al. Pediatr Blood Cancer. 2017 Jun;64(6):10.1002/pbc.26390. doi: 10.1002/pbc.26390. Epub 2016 Dec 21. Pediatr Blood Cancer. 2017. PMID: 28000344 Free PMC article.

5

Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.

Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, Treadwell MJ. Kayle M, et al. Among authors: paulukonis s. Pediatr Blood Cancer. 2020 May;67(5):e28152. doi: 10.1002/pbc.28152. Epub 2020 Mar 8. Pediatr Blood Cancer. 2020. PMID: 32147964 Free PMC article.

6

Sickle cell disease among Latinx in California.

Valle J, Baker JR, Madrigal D, Ferrerosa J, Paulukonis S. Valle J, et al. Among authors: paulukonis s. PLoS One. 2022 Oct 27;17(10):e0276653. doi: 10.1371/journal.pone.0276653. eCollection 2022. PLoS One. 2022. PMID: 36301979 Free PMC article.

7

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Paulukonis ST, Eckman JR, Snyder AB, Hagar W, Feuchtbaum LB, Zhou M, Grant AM, Hulihan MM. Paulukonis ST, et al. Public Health Rep. 2016 Mar-Apr;131(2):367-75. doi: 10.1177/003335491613100221. Public Health Rep. 2016. PMID: 26957672 Free PMC article.

8

Cancer specific survival in patients with sickle cell disease.

Brunson A, Keegan THM, Mahajan A, Paulukonis S, Wun T. Brunson A, et al. Among authors: paulukonis s. Br J Haematol. 2019 Apr;185(1):128-132. doi: 10.1111/bjh.15687. Epub 2018 Nov 22. Br J Haematol. 2019. PMID: 30467842 Free PMC article.

9

Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach.

Johnston EE, Adesina OO, Alvarez E, Amato H, Paulukonis S, Nichols A, Chamberlain LJ, Bhatia S. Johnston EE, et al. Among authors: paulukonis s. J Palliat Med. 2020 Jan;23(1):24-32. doi: 10.1089/jpm.2018.0649. Epub 2019 Aug 7. J Palliat Med. 2020. PMID: 31390292

10

Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data.

Kanter J, Meier ER, Hankins JS, Paulukonis ST, Snyder AB. Kanter J, et al. Among authors: paulukonis st. JAMA Health Forum. 2021 Oct 1;2(10):e213467. doi: 10.1001/jamahealthforum.2021.3467. JAMA Health Forum. 2021. PMID: 36218900 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters